These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8927633)

  • 21. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple activated oxygen species in P450 catalysis: contributions To specificity in drug metabolism.
    Coon MJ; Vaz AD; McGinnity DF; Peng HM
    Drug Metab Dispos; 1998 Dec; 26(12):1190-3. PubMed ID: 9860926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
    Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
    J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How the pharmacogenetics of cytochrome P450 enzymes may affect prescribing.
    Roberts RL; Begg EJ; Joyce PR; Kennedy MA
    N Z Med J; 2002 Mar; 115(1150):137-40. PubMed ID: 12013308
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of obesity on the cytochrome P450 enzyme system.
    Kotlyar M; Carson SW
    Int J Clin Pharmacol Ther; 1999 Jan; 37(1):8-19. PubMed ID: 10027478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P-450: the Japanese connection.
    Gelboin HV
    Jpn J Cancer Res; 1993 Feb; 84(2):inside front cover. PubMed ID: 8463126
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of cytochrome p450 by inflammatory mediators: why and how?
    Morgan ET
    Drug Metab Dispos; 2001 Mar; 29(3):207-12. PubMed ID: 11181485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochrome P450 polymorphism--molecular, metabolic and pharmacogenetic aspects. I. Mechanisms of activity of cytochrome P450 monooxygenases.
    Pachecka J; Tomaszewski P; Kubiak-Tomaszewska G
    Acta Pol Pharm; 2008; 65(3):303-6. PubMed ID: 18646549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.
    Halpert JR; Domanski TL; Adali O; Biagini CP; Cosme J; Dierks EA; Johnson EF; Jones JP; Ortiz de Montellano P; Philpot RM; Sibbesen O; Wyatt WK; Zheng Z
    Drug Metab Dispos; 1998 Dec; 26(12):1223-31. PubMed ID: 9860932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modern approaches for the phenotyping of cytochrome P450 enzymes in children.
    Magliocco G; Daali Y
    Expert Rev Clin Pharmacol; 2020 Jul; 13(7):671-674. PubMed ID: 32500746
    [No Abstract]   [Full Text] [Related]  

  • 34. Human P450s in the metabolism of drugs: molecular modelling of enzyme-substrate interactions.
    Lewis DF
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):5-8. PubMed ID: 16922648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substituent elimination from p-substituted phenols by cytochrome P450. ipso-Substitution by the oxygen atom of the active species.
    Ohe T; Mashino T; Hirobe M
    Drug Metab Dispos; 1997 Jan; 25(1):116-22. PubMed ID: 9010638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro approaches can predict human drug metabolism.
    Bickett DJ; MacKenzie PI; Veronese ME; Miners JO
    Trends Pharmacol Sci; 1993 Aug; 14(8):292-4. PubMed ID: 8249146
    [No Abstract]   [Full Text] [Related]  

  • 37. Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles.
    Lewis DF
    Toxicology; 2000 Apr; 144(1-3):197-203. PubMed ID: 10781888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of baicalin on liver microsomal cytochrome P450 system].
    Hou YN; Zhu XY; Cheng GF
    Yao Xue Xue Bao; 2000 Dec; 35(12):890-2. PubMed ID: 12567908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
    Baranczewski P; Edlund PO; Postlind H
    J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs.
    Guengerich FP; Hosea NA; Parikh A; Bell-Parikh LC; Johnson WW; Gillam EM; Shimada T
    Drug Metab Dispos; 1998 Dec; 26(12):1175-8. PubMed ID: 9860923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.